Work

Pre-emptive DPYD genotyping and fluoropyrimidine dose optimisation: Dose tolerance and survival in cancer patients

Year: 2026

Type: article

Source: Journal of Oncology Pharmacy Practice

DOI: 10.1177/10781552261445956

Authors: Sarah Glewis, Senthil Lingaratnam, Tim Spelman, Jeanne Tie, Jennifer H Martin, Marliese Alexander, Michael Michael

Institutions: The University of Melbourne, Peter MacCallum Cancer Centre, Walter and Eliza Hall Institute of Medical Research, University of Newcastle Australia

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7161936859

FWCI:

Cites: 15

Cited by:

Related to: